Ensure appropriate access to 17P, a synthetic version of the hormone progesterone, by identifying high-risk women, reducing barriers to treatment receipt and completion, coordinating care, etc.
Create financial incentives or remove financial disincentives to affect consumer choices and incentivize provision of cost efficient health care services